NIOX Group (LON:NIOX) Issues Earnings Results

NIOX Group (LON:NIOX) issued its quarterly earnings results on Wednesday. The company reported GBX 1.41 earnings per share (EPS) for the quarter, Digital Look Earnings reports. NIOX Group had a net margin of 14.74% and a return on equity of 10.01%.

NIOX Group Stock Down 4.3%

Shares of NIOX Group stock traded down GBX 3 during trading hours on Thursday, reaching GBX 66. 215,753 shares of the company’s stock were exchanged, compared to its average volume of 799,601. The stock has a market cap of £277.77 million, a P/E ratio of 40.24 and a beta of 0.92. The company has a 50 day moving average of GBX 65.69 and a two-hundred day moving average of GBX 61.63. The company has a current ratio of 4.60, a quick ratio of 1.94 and a debt-to-equity ratio of 1.06. NIOX Group has a fifty-two week low of GBX 53.84 and a fifty-two week high of GBX 76.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.